Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 26807 | 9.85 |
09:34 ET | 54393 | 10.2 |
09:36 ET | 12582 | 10.2177 |
09:38 ET | 3784 | 10.1406 |
09:39 ET | 10607 | 10.46 |
09:41 ET | 2850 | 10.39 |
09:43 ET | 3000 | 10.3216 |
09:45 ET | 597 | 10.38 |
09:48 ET | 1307 | 10.315 |
09:50 ET | 200 | 10.38 |
09:52 ET | 100 | 10.39 |
09:54 ET | 1325 | 10.38 |
09:56 ET | 700 | 10.335 |
09:57 ET | 5234 | 10.3933 |
09:59 ET | 2614 | 10.6 |
10:01 ET | 1200 | 10.5499 |
10:03 ET | 9746 | 10.5594 |
10:06 ET | 1475 | 10.67 |
10:08 ET | 4414 | 10.8 |
10:10 ET | 200 | 10.8 |
10:12 ET | 1610 | 10.7105 |
10:14 ET | 200 | 10.8 |
10:15 ET | 1196 | 10.84 |
10:17 ET | 11120 | 11 |
10:19 ET | 1987 | 11.0863 |
10:21 ET | 4140 | 11.165 |
10:24 ET | 1500 | 11.22 |
10:26 ET | 3929 | 11.26 |
10:28 ET | 8288 | 11.61 |
10:30 ET | 3277 | 11.395 |
10:32 ET | 11031 | 10.9722 |
10:33 ET | 1300 | 11 |
10:35 ET | 100 | 11.13 |
10:37 ET | 2420 | 11.115 |
10:39 ET | 1725 | 10.97 |
10:42 ET | 6853 | 10.87 |
10:44 ET | 966 | 10.83 |
10:48 ET | 10770 | 10.74 |
10:50 ET | 400 | 10.74 |
10:51 ET | 100 | 10.74 |
10:57 ET | 1213 | 10.815 |
11:00 ET | 2864 | 10.96 |
11:02 ET | 2800 | 11.16 |
11:04 ET | 11310 | 11.34 |
11:06 ET | 2538 | 11.325 |
11:08 ET | 100 | 11.335 |
11:11 ET | 300 | 11.2826 |
11:13 ET | 1716 | 11.2321 |
11:15 ET | 200 | 11.22 |
11:18 ET | 343 | 11.15 |
11:20 ET | 5338 | 11.1301 |
11:22 ET | 1500 | 11.11 |
11:24 ET | 1188 | 11.12 |
11:26 ET | 1016 | 11.175 |
11:27 ET | 400 | 11.17 |
11:29 ET | 400 | 11.17 |
11:31 ET | 844 | 11.1 |
11:33 ET | 200 | 11.175 |
11:36 ET | 550 | 11.175 |
11:38 ET | 300 | 11.175 |
11:40 ET | 300 | 11.18 |
11:42 ET | 2170 | 11.21 |
11:44 ET | 600 | 11.2 |
11:45 ET | 700 | 11.135 |
11:47 ET | 500 | 11.135 |
11:49 ET | 500 | 11.135 |
11:51 ET | 300 | 11.135 |
11:54 ET | 629 | 11.04 |
11:56 ET | 695 | 10.92 |
11:58 ET | 20414 | 10.88 |
12:02 ET | 408 | 10.8703 |
12:03 ET | 400 | 10.8999 |
12:05 ET | 2121 | 10.865 |
12:07 ET | 194 | 10.8908 |
12:09 ET | 4991 | 10.74 |
12:12 ET | 300 | 10.7535 |
12:14 ET | 200 | 10.74 |
12:16 ET | 200 | 10.74 |
12:18 ET | 100 | 10.745 |
12:20 ET | 1200 | 10.79 |
12:21 ET | 902 | 10.755 |
12:23 ET | 250 | 10.7 |
12:25 ET | 850 | 10.7 |
12:27 ET | 1400 | 10.765 |
12:32 ET | 600 | 10.74 |
12:34 ET | 1043 | 10.7 |
12:36 ET | 300 | 10.7 |
12:38 ET | 200 | 10.7 |
12:39 ET | 318 | 10.7 |
12:41 ET | 2928 | 10.805 |
12:43 ET | 200 | 10.81 |
12:45 ET | 3900 | 10.81 |
12:48 ET | 2097 | 10.91 |
12:50 ET | 500 | 10.905 |
12:52 ET | 100 | 10.895 |
12:54 ET | 100 | 10.905 |
12:56 ET | 411 | 10.9047 |
12:57 ET | 650 | 10.905 |
12:59 ET | 200 | 10.86 |
01:01 ET | 400 | 10.89 |
01:03 ET | 802 | 10.895 |
01:06 ET | 100 | 10.895 |
01:08 ET | 2100 | 10.9 |
01:10 ET | 200 | 10.9 |
01:12 ET | 600 | 10.89 |
01:14 ET | 800 | 10.9 |
01:15 ET | 300 | 10.9 |
01:17 ET | 700 | 10.87 |
01:19 ET | 500 | 10.9 |
01:21 ET | 1100 | 10.93 |
01:24 ET | 3673 | 10.975 |
01:26 ET | 1200 | 11.08 |
01:28 ET | 1400 | 11.04 |
01:30 ET | 900 | 11.04 |
01:32 ET | 500 | 11.04 |
01:33 ET | 1750 | 11.035 |
01:35 ET | 300 | 11.035 |
01:37 ET | 800 | 11.035 |
01:39 ET | 1581 | 11.16 |
01:42 ET | 100 | 11.145 |
01:44 ET | 2003 | 11.26 |
01:46 ET | 1517 | 11.205 |
01:48 ET | 3900 | 11.285 |
01:50 ET | 1400 | 11.295 |
01:51 ET | 700 | 11.295 |
01:53 ET | 2837 | 11.14 |
01:55 ET | 300 | 11.14 |
01:57 ET | 2000 | 11.14 |
02:00 ET | 1577 | 11.115 |
02:02 ET | 300 | 11.115 |
02:04 ET | 1427 | 11.06 |
02:06 ET | 470 | 11.08 |
02:09 ET | 34070 | 11.445 |
02:11 ET | 1302 | 11.465 |
02:13 ET | 5093 | 11.4 |
02:15 ET | 100 | 11.415 |
02:20 ET | 914 | 11.365 |
02:22 ET | 500 | 11.32 |
02:24 ET | 1150 | 11.335 |
02:26 ET | 200 | 11.34 |
02:29 ET | 1607 | 11.35 |
02:31 ET | 400 | 11.35 |
02:33 ET | 843 | 11.365 |
02:36 ET | 200 | 11.365 |
02:38 ET | 356 | 11.35 |
02:40 ET | 800 | 11.35 |
02:42 ET | 9434 | 11.48 |
02:44 ET | 100 | 11.455 |
02:45 ET | 300 | 11.455 |
02:47 ET | 450 | 11.43 |
02:49 ET | 100 | 11.455 |
02:51 ET | 300 | 11.455 |
02:54 ET | 5166 | 11.485 |
02:56 ET | 4500 | 11.5259 |
02:58 ET | 5739 | 11.4873 |
03:00 ET | 4350 | 11.49 |
03:02 ET | 1415 | 11.5 |
03:03 ET | 1400 | 11.485 |
03:05 ET | 1323 | 11.505 |
03:07 ET | 3900 | 11.5299 |
03:09 ET | 15010 | 11.53 |
03:12 ET | 5287 | 11.675 |
03:14 ET | 8641 | 11.73 |
03:16 ET | 5786 | 11.735 |
03:18 ET | 15803 | 11.58 |
03:20 ET | 5301 | 11.47 |
03:21 ET | 2300 | 11.585 |
03:23 ET | 7135 | 11.62 |
03:25 ET | 3330 | 11.65 |
03:27 ET | 2447 | 11.75 |
03:30 ET | 10602 | 11.52 |
03:32 ET | 4293 | 11.58 |
03:34 ET | 7702 | 11.67 |
03:36 ET | 2319 | 11.68 |
03:38 ET | 8354 | 11.75 |
03:39 ET | 5393 | 11.75 |
03:41 ET | 10465 | 11.74 |
03:43 ET | 7822 | 11.71 |
03:45 ET | 7810 | 11.7 |
03:48 ET | 2200 | 11.75 |
03:50 ET | 5976 | 11.74 |
03:52 ET | 4926 | 11.84 |
03:54 ET | 16096 | 11.96 |
03:56 ET | 18476 | 12.14 |
03:57 ET | 34818 | 11.98 |
03:59 ET | 28649 | 11.94 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 659.4M | -14.6x | --- |
Nano-X Imaging Ltd | 501.0M | -8.0x | --- |
Cibus Inc | 392.5M | -0.9x | --- |
MaxCyte Inc | 480.9M | -13.0x | --- |
Coretag Inc | 1.1B | -13.1x | --- |
Orchestra Biomed Holdings Inc | 189.7M | -3.6x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $659.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.79 |
EPS | $-0.82 |
Book Value | $0.80 |
P/E Ratio | -14.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.